Latest Breaking News On - Glaxosmithkline china investment - Page 1 : comparemela.com

Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline - Extending the Cooperation in Pulmonary Arterial Hypertension News provided by Share this article Share this article SHANGHAI, Mar. 17, 2021 /PRNewswire/ Zhongchao Inc. (NASDAQ: ZCMD) ( Zhongchao or the Company ), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced the renewal of its partnership with the China Association for Health Promotion and Education and GlaxoSmithKline (China) Investment Limited to continue the medical education program Pulmonary Arterial Hypertension Online Course – Connections with Famous Hospitals ( PAH Project ) in 2021. The PAH Project aims to promote the implementation of the multidisciplinary treatment model of pulmonary hypertension and improve doctors ability to solve clinical problems. In 2020, more than 200 experts in pulmonary hyp

Sherry zhengWeiguang yangPei xuSunshine health forumsGlaxosmithkline china investmentChina association for health promotionPrnewswire zhongchao incZhongchao incWeitian groupChina associationHealth promotionInvestment limitedArterial hypertension online courseChief executive officerBeijing chinaPrivate securities litigation reform act